Shandong Longxin Pharmaceutical Co., Ltd. 50,000 tons of salicylic acid complete industrial chain and national research and development pilot base projectenvironmental impact assessment public participation in the second information announcement

According to the "Environmental Impact Assessment Law of the People's Republic of China", "Measures for Public Participation in Environmental Impact Assessment" (Ministry Order No. 4) and relevant regulations on the environmental impact assessment of construction projects, the construction situation and environmental impact assessment of this project will be publicized for a broad understanding The attitude of the public from all walks of life towards the project and the opinions and suggestions on environmental protection are subject to the supervision of the public.   一、环境影响报告书征求意见稿全文的网络链接及查阅纸质报告书的方式和途径   (1)环境影响报告书征求意见稿全文的获取方式:   链接:https://pan.baidu.com/s/1GzHL3HzOvOTVbxyA-wk1Aw   提取码:w4j9   (2)公众认为必要时需索取有关补充信息及查阅纸质版报告,请于本公示公布10个工作日内与建设单位或评价单位联系,联系方式如下:   建设单位:山东隆信药业有限公司   通讯地址:临淄区辛店街道乙烯路299号   联 系 人:王经理   联系电话:18653326898   邮箱:7537689@163.com   二、征求意见的公众范围   (1)征求公众意见的范围为项目附近村民或有关团体、组织管理部门。   (2)如公众需要进一步了解该项目的其它信息,可向建设单位咨询。   三、公众意见表的网络链接:   环境影响评价公众参与意见表点击下列链接获取。   链接:https://pan.baidu.com/s/1GzHL3HzOvOTVbxyA-wk1Aw   提取码:w4j9   四、公众提出意见的方式和途径;   公众可通过上述网络链接自行下载公众意见表,填写后通过电子邮件或信函的方式向建设单位提交对拟建项目建设的书面意见,或采取电话方式进行沟通,提交意见表的公众请注明填表日期、真实姓名和有效联系方式,以便根据需要及时向公众反馈意见。   五、公众提出意见的起止时间   公众提出意见的时间为本公示公布之日起10个工作日。   山东隆信药业有限公司   2020年8月25日

15

2021

/

09

Cleaner production audit publicity

Shandong Longxin Pharmaceutical Co., Ltd. belongs to the basic chemical raw material manufacturing industry, and uses toxic and harmful raw materials - phenol, sulfuric acid, liquid caustic soda, methanol, etc. in the production process. According to the "Cleaner Production Auditing Measures", dual-owned enterprises that use toxic and harmful raw materials should implement mandatory cleaner production audits. According to the "Cleaner Production Promotion Law of the People's Republic of China", "Cleaner Production Auditing Measures", "Regulations on Cleaner Production Auditing Procedures for Key Enterprises" (Huanfa [2005] No. 151), and "Guidelines for Cleaner Production Audit Evaluation and Acceptance" ( Huanban Technology [2018] No. 5), "Shandong Province Cleaner Production Audit Implementation Rules" and Zibo Ecological Environment Bureau "Notice on Issuing the List of Companies Implementing Mandatory Cleaner Production Audit in Zibo in 2020" (Zihuan Letter [2020] No. 76), Shandong Longxin Pharmaceutical Co., Ltd. was listed as an enterprise implementing mandatory cleaner production audits in Zibo City, requiring the implementation of cleaner production audits. To this end, on the basis of standardizing its own management and maintaining a high resource utilization rate, our company conducts clean production audits to further improve the efficiency of resource utilization, improve the environment, and create greater economic benefits for the enterprise. This round of audit is the first round of clean production audit of our company. From May 2020 to December 2020, under the guidance of the auditors of Zibo Kangyuan Environmental Protection Technology Co., Ltd., the company successfully completed the first round of clean production audits. In the audit preparation stage, the consulting unit instructed our company to set up a production audit team, formulate audit work plans, launch publicity and education, and conduct cleaner production training; In the pre-audit stage, a current situation investigation was carried out, focusing on the company's general situation, production status, environmental protection status, management status, evaluation of pollution production and pollution status, comparison of pollution production and pollution status of similar enterprises at home and abroad, analysis of pollution production reasons, and evaluation conclusions. Review key points (30,000 tons/year salicylic acid plant), set clean production goals and propose and implement no-low-cost plans; In the audit stage, the actual measurement of the key materials was carried out, the balance was established and the causes of waste were analyzed. In the program generation and screening stage, 9 cleaner production programs were proposed, including 6 no/low-cost programs and 3 medium/high-cost programs; In the determination stage of the plan, the high-cost plan of this round of review process - energy-saving transformation of the stirring system of the F7 salicylic acid carboxylation reactor was determined, and the implementation of this plan was determined through technical assessment, environmental assessment and economic assessment; At the implementation stage of the plan, our company has organized the implementation of the proposed plans. As of October 31, 2020, the company's 9 clean production plans have all been implemented. The company has implemented 9 plans with an investment of 4.117 million yuan. After the audit, the actual saving of electricity consumption is 1.7202 million kwh/a, steam saving is 3650 t/a, and the economic benefit is 5.1188 million yuan/a. The environmental benefit generated is to reduce waste water discharge. The amount is about 1749t/a. After the audit, the company's clean production level is relatively high. During this round of review, the company has not had any major or particularly major pollution accidents. At the same time, the company's pollutants can meet the concentration requirements, total requirements and so on. Through the clean production audit, Shandong Longxin Pharmaceutical Co., Ltd. truly embodies the principle of "energy saving, consumption reduction, pollution reduction, and efficiency enhancement" of clean production, which has injected new vitality into the development of the enterprise.

15

2021

/

09

< 12 >